Regulation

Filter

Current filters:

None

Popular Filters

1 to 25 of 2755 results

Orexigen's Mysimba approved in the EU for obese and overweight patients with co-morbidities

Orexigen's Mysimba approved in the EU for obese and overweight patients with co-morbidities

27-03-2015

Obesity speciality Orexigen has been granted marketing authorization by the European Commission for Mysimba…

EuropeMetabolicsMysimbaOrexigen TherapeuticsPharmaceuticalRegulation

Global drugmakers call for improvement of Russian pharma legislation

27-03-2015

Leading global pharmaceutical manufacturers operating in the Russian market have expressed their concerns…

FinancialPharmaceuticalProductionRegulationRussia

Slow growth forecast for Germany’s pharma market

27-03-2015

While Germany is the leading pharmaceutical market in Europe, valued at $58.6 billion in 2014, the sector…

GermanyMarkets & MarketingPharmaceuticalPricingRegulation

Novo Nordisk rises as it says it plans to resubmit Tresiba and Ryzodeg NDAs in USA

Novo Nordisk rises as it says it plans to resubmit Tresiba and Ryzodeg NDAs in USA

27-03-2015

Danish diabetes care giant Novo Nordisk has decided to submit the pre-specified interim analysis of DEVOTE…

DiabetesNovo NordiskPharmaceuticalRegulationResearchRyzodegTresibaUSA

Sanofi Pasteur’s Quadracel vaccine gets FDA approval

26-03-2015

French pharma major Sanofi’s (Euronext: SAN) Sanofi Pasteur has received approval from the US Food…

PharmaceuticalQuadracelRegulationSanofiSanofi PasteurUSAVaccines

FDA approval for Emergent BioSolutions’ Anthrasil

25-03-2015

US biopharma company Emergent BioSolutions has received approval from the US Food and Drug Administration…

AnthrasilAntibiotics and Infectious diseasesEmergent BioSolutionsPharmaceuticalRegulationUSA

European Commission approves Santen Pharma’s Ikervis for eye disease

25-03-2015

Japanese drugmaker Santen Pharmaceutical has received approval of the Marketing Authorization Application…

EuropeIkervisOphthalmicsPharmaceuticalRegulationSanten Pharmaceuticals

Ono Pharma gets South Korea approval of Opdivo

24-03-2015

Japanese drugmaker Ono Pharmaceutical has received approval from South Korea’s Ministry of Food and…

BiotechnologyBristol-Myers SquibbOncologyOno PharmaceuticalOpdivoRegulationSouth Korea

FDA safety review of Zyprexa Relprevv calls for no changes to current prescribing

24-03-2015

The US Food and Drug Administration has concluded a review of a study undertaken to determine the cause…

Eli LillyHealthcareNeurologicalPharmaceuticalRegulationUSAZyprexa Relprevv

Regenerative Medicine Expert Group publishes report with action plan for UK implementation

Regenerative Medicine Expert Group publishes report with action plan for UK implementation

24-03-2015

The Regenerative Medicine Expert Group has published its report ‘Building on our own potential: a UK…

BiotechnologyPricingRegulationResearchUK

Novo Nordisk’s Saxenda gains EU approval for obesity

24-03-2015

There was good news for Danish diabetes care giant Novo Nordisk yesterday, when, late in the day, the…

DiabetesEuropeMetabolicsNovo NordiskPharmaceuticalRegulationSaxendaVictoza

Pfizer and Lilly gear up to resume Phase III chronic pain program for tanezumab

23-03-2015

US pharma majors Pfizer and Eli Lilly both saw their shares rise in pre-market trading today, as they…

Eli LillyLicensingNeurologicalPfizerPharmaceuticalRegulationUSA

Pfenex gets early HSR clearance for collaboration with Hospira

23-03-2015

The US Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino…

BiosimilarsBiotechnologyGenentechHospiraLicensingLucentisOphthalmicsPF582PfenexRegulationRocheUSA

Ukranian pharma organization APRaD meets with European bodies on domestic health reform

Ukranian pharma organization APRaD meets with European bodies on domestic health reform

23-03-2015

The Ukrainian pharma organization, the Association of Pharmaceutical Research and Development (APRaD)…

BrusselsPharmaceuticalPoliticsRegulationUkraine

IQWiG now finds added benefit for Provenge

23-03-2015

Reversing a previous negative opinion, the German Institute for Quality and Efficiency in Health Care…

BiotechnologyDendreonGermanyOncologyPricingProvengeRegulationValeant Pharmaceutical International

Farmaindustria defends the non-interchangeability principle for biologic and biosimilar medicines

21-03-2015

Speaking at the first Biological Medicines Forum organized by the Associations last week, the president…

BiosimilarsBiotechnologyPatents & Trade marksRegulationSpain

Aurobindo gains tentative US FDA approval for generic Vimpat

21-03-2015

Indian drugmaker Aurobindo Pharma has received tentative approval from the US Food and Drug Administration…

Aurobindo PharmaGenericslacosamide Tablet and InjectionLegalNeurologicalRegulationUCBUSAVimpat

Amgen files for Repatha approval in Japan

20-03-2015

Leading USA-based biotech firm Amgen has filed for approval of Repatha (evolocumab) for the treatment…

AmgenAstellas PharmaBiotechnologyCardio-vascularevolocumabJapanRegulationRepatha

Dilaforette's sevuparin granted orphan drug designation by FDA in sickle-cell disease

Dilaforette's sevuparin granted orphan drug designation by FDA in sickle-cell disease

20-03-2015

Dilaforette, a portfolio company of Karolinska Development, a Nordic investor in life sciences, has been…

DilaforetteHematologyPharmaceuticalRegulationResearchSevuparinSwedenUSA

Compliance at home and in emerging markets the key challenges to pharma, says study

Compliance at home and in emerging markets the key challenges to pharma, says study

20-03-2015

The UK pharma sector expects one of its biggest challenges to be the risk of incurring fines as they…

Markets & MarketingPharmaceuticalProductionRegulationUK

Mixed FDA advisory panel views on GSK’s Breo Ellipta

20-03-2015

There was conflicting news yesterday for UK pharma major GlaxoSmithKline and US partner Theravance from…

Breo ElliptaGlaxoSmithKlinePharmaceuticalRegulationRespiratory and Pulmonary

1 to 25 of 2755 results

Back to top